Study to identify the new molecules for liver carcinogenesis from chronic liver deseases and for cancer progeresssion.

Study to identify the new molecules for liver carcinogenesis from chronic liver deseases and for cancer progeresssion. - Study for liver carcinogenesis.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008652

Enrollment

100

Registered

2012-08-08

Start date

2007-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic liver diseases and hepatocellular carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients of hepatocellular carcinoma we can take informed concent to use the liver specimens obtained in surgical treatment or tumor biopsy for diagnosis, regardless of sex or age.

Exclusion criteria

Exclusion criteria: 1. The patients who have poorly controlled cardiovascular, hematologic or pulmonary disease 2. The patients with pregnancy 3. The patients with severe depression or other psychiatric disorders

Design outcomes

Primary

Measure	Time frame
Detection of new molecules, which overexpressed in hepatocellular carcinoma compared to non-tumor tissue.	—

Countries

Japan

Contacts

Public ContactYoichi Hiasa

Ehime University Graduate School of Medicine Department of Gastroenterology and Metabology

hiasa@m.ehime-u.ac.jp+81-89-960-5308

Outcome results